logo-loader
viewHeartseed

Heartseed developing heart failure treatment

Heartseed Inc CEO Keiichi Fukuda sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Tokyo-based biotechnology company is developing a treatment for heart failure, and recently raised $26M in Series B funding.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Primary Health Properties 'in robust shape' and playing its part in fight...

Primary Health Properties PLC's  (LON:PHP) Harry Hyman and Richard Howell tell Proactive London's Andrew Scott they're working with health authorities to utilise its properties better during the current coronavirus crisis. They add that all of its rents are effectively guaranteed by the...

15 hours, 26 minutes ago

2 min read